Evidence map›Paper›PMID 39280401›Full record

ArticleCureus2024

Necrotizing Fasciitis of the Lower Extremity Treated With Continuous Local Antibiotic Perfusion.

Nana Tomaru, Hideharu Nakamura, Takaya Makiguchi, Yumi Yamada, Satoshi Yokoo

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nana TomaruDepartment of Plastic Surgery, National Hospital Organization (NHO) Takasaki General Medical Center, Takasaki, JPN.
Hideharu NakamuraDepartment of Plastic Surgery, National Hospital Organization (NHO) Takasaki General Medical Center, Takasaki, JPN.
Takaya MakiguchiDepartment of Oral and Maxillofacial Surgery and Plastic Surgery, Gunma University Graduate School of Medicine, Maebashi, JPN.
Yumi YamadaDepartment of Plastic Surgery, National Hospital Organization (NHO) Takasaki General Medical Center, Takasaki, JPN.
Satoshi YokooDepartment of Oral and Maxillofacial Surgery and Plastic Surgery, Gunma University Graduate School of Medicine, Maebashi, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Necrotizing fasciitis (NF) is a severe soft tissue infection that can spread rapidly throughout the body, often resulting in fatal outcomes. Negative pressure wound therapy (NPWT) enhances wound healing by applying local negative pressure, and its effectiveness in managing NF has been documented. However, NPWT creates a semi-closed environment at the wound site, posing a risk of infection. Continuous local antibiotic perfusion (CLAP) is an innovative approach that uses localized infusion to deliver high concentrations of antibiotics continuously to the affected area via NPWT. CLAP includes intramedullary antibiotic perfusion (iMAP), which involves the intrathecal administration of antimicrobials, and intra-soft tissue antibiotic perfusion (iSAP), which targets the soft tissue. Previous studies have highlighted the efficacy of CLAP in controlling infections in both bone and soft tissue. Here, we present two cases of lower extremity NF treated with iSAP. In both cases, effective infection control and accelerated wound healing were achieved, leading to wound closure. These outcomes suggest that iSAP is a useful treatment modality for NF that offers a reduced treatment period and minimizes the procedural burden on patients.

Indexed as

continuous local antibiotics perfusiongentamicinintra-soft tissue antibiotics perfusionnecrotizing fasciitisnegative pressure wound therapy

Identifiers

PMID39280401
PMCPMC11398856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.